A new decade for patients with atrial fibrillation
Post-COVID-19 investigations of the atrial fibrillation patient should include an ECG and cardiac MRI scan to determine the presence of COVID-19 myocarditis.
You will learn:
• Lessons from more than a decade of using non-vitamin K oral anticoagulants (NOACs) for stroke prevention in the patient with atrial fibrillation (AF)
• Assessment of stroke risk and key factors to consider in the patient with AF
• Real-world and clinical trial evidence for the reduction of risk in AF patients with diabetes who are using rivaroxaban
• Post-COVID-19 cardiac work-up in patients with AF.
WEBINAR HELD ON 29 MARCH 2021
ATTENTIONKindly note that if you attended the live webinar, you have already received 1 CPD point and will not be permitted to receive additional points for the report. Should this occur, the HPCSA will only record the 1 CPD point from the live webinar, invalidating any additional CPD points from the report.
Please note deNovo Medica ensures uploading of your CPD points to the HPCSA: please don’t upload these yourself.
To access this module, please register or login: